Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors and
pharmaceutical compositions comprising the same are described. Methods of
using such antibodies, peptides, and mimetics in therapeutic,
prophylactic, imaging and diagnostic applications are disclosed.
